Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosilate Dose Exploration for General Anesthesia
NCT04908553Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Jul 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in general anesthesia (3 arms), sponsored by Tongji Hospital. Primary endpoints: Incidence of hypotension during the anesthesia and Rate of Successful sedation during the anesthesia. Started Jul 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT04908553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04908553.